- Enrolling by invitationPHASE2, PHASE3
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
This study looks at a new daily medicine called deucrictibant for people aged 12 and over with hereditary angioedema (HAE). It's for long-term use to treat sudden swelling attacks, including dangerous swelling in the throat. Researchers want to see how safe and effective it is over time.
For: Hereditary Angioedema · Hereditary Angioedema Type I · Hereditary Angioedema Type IIUnited States · Argentina · Australia - RecruitingPHASE3
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
This study is looking at a new tablet, deucrictibant, for teenagers and adults with Hereditary Angioedema (HAE). It aims to see if taking it daily can safely and effectively reduce painful swelling attacks over a long period.
For: Hereditary Angioedema (HAE)United States · Argentina · Australia - Active not recruitingPHASE3
Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
This study is looking at a new tablet, deucrictibant, to see if it can help prevent swelling attacks in people with Hereditary Angioedema (HAE). It includes adults and children aged 12 and over, comparing the new drug to a dummy pill (placebo).
For: Hereditary Angioedema (HAE)United States · Argentina · Brazil - RecruitingPHASE3
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
This study is testing a new medicine, deucrictibant, for adults with a rare swelling condition called acquired angioedema (AAE). It looks at whether the medicine can prevent swelling attacks and also treat them when they happen, compared to a dummy pill.
For: Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)United States · Australia · Austria